Ryuzou Ueda

Q: What Schools Are Affiliated With Ryuzou Ueda

Ryuzou Ueda is affiliated with the following schools: Nagoya City University, Nagasaki University, Nagoya University, Aichi Medical University

Ryuzou Ueda's AcademicInfluence.com Rankings

Ryuzou Ueda

Medical

#2389

World Rank

#2811

Historical Rank

Hematology

#31

World Rank

#36

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Ryuzou Ueda Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ryuzou Ueda's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. (1999) (822)
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. (2012) (553)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. (2007) (417)
Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. (1993) (411)
Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. (2003) (352)
Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. (2010) (338)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. (2004) (330)
p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. (1992) (313)
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. (2006) (305)
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. (2014) (302)
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. (2002) (300)
Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene (2002) (297)
Three distinct regions involved in 3p deletion in human lung cancer. (1992) (294)
Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma (2004) (294)
Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain (2002) (289)
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. (2005) (278)
Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. (1991) (275)
Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma (2000) (269)
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. (2004) (255)
CCR4 as a novel molecular target for immunotherapy of cancer (2006) (229)
The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. (1991) (225)
Clinicopathologic Study of CD56 (NCAM)‐Positive Angiocentric Lymphoma Occurring in Sites Other than the Upper and Lower Respiratory Tract (1995) (223)
Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. (1992) (223)
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection (2006) (221)
Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. (1995) (220)
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. (2001) (217)
Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. (2003) (214)
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas (2007) (209)
CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. (1997) (207)
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. (2000) (207)
Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma (2010) (205)
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study (2015) (195)
Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. (1991) (191)
Enhanced Natural Killer Cell Binding and Activation by Low-Fucose IgG1 Antibody Results in Potent Antibody-Dependent Cellular Cytotoxicity Induction at Lower Antigen Density (2005) (190)
MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies (2000) (189)
Smoking increases the treatment failure for Helicobacter pylori eradication. (2006) (189)
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. (1997) (188)
Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. (1998) (184)
Serological analysis of cell surface antigens of malignant human brain tumors. (1978) (184)
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress (2010) (178)
Hepatitis B Virus Genotype Distribution among Chronic Hepatitis B Virus Carriers in Shanghai, China (2001) (178)
CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas with Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified (2004) (172)
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients (2015) (168)
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma (2009) (158)
Cell surface antigens of human renal cancer defined by autologous typing (1979) (157)
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. (2004) (155)
The CC Chemokine Receptor 4 as a Novel Specific Molecular Target for Immunotherapy in Adult T-Cell Leukemia/Lymphoma (2004) (149)
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. (1981) (148)
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. (2004) (145)
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. (1996) (144)
Differential expression of the c‐kit proto‐oncogene in germ cell tumours (1995) (144)
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing (2012) (143)
Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non‐small cell lung cancer (2004) (141)
Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis (2001) (140)
Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. (1996) (135)
Expression of costimulatory molecules in human leukemias. (1996) (133)
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. (2006) (132)
Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F) (2002) (129)
In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. (1995) (127)
Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. (2006) (124)
New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism 1 (1998) (122)
MRP8/ABCC11 directly confers resistance to 5-fluorouracil (2007) (121)
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients (2008) (120)
Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes (1999) (120)
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries. (2012) (119)
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G (2002) (118)
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas (2007) (117)
Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. (1989) (116)
Stevens–Johnson Syndrome associated with mogamulizumab treatment of adult T‐cell leukemia / lymphoma (2013) (114)
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study. (2015) (114)
API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. (2001) (112)
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease (2003) (112)
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model (2009) (111)
Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. (1996) (108)
Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. (2002) (107)
Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors. (1995) (103)
MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. (1993) (101)
Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. (1993) (101)
The determinants of sensitivity and acquired resistance to gemcitabine differ in non–small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity (2006) (100)
A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. (1994) (100)
Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. (1993) (99)
Regulatory T‐cell function of adult T‐cell leukemia/lymphoma cells (2007) (99)
Clinicopathologic study of large cell anaplastic lymphoma (ki‐1‐positive large cell lymphoma) among the japanese (1991) (98)
Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations (2001) (98)
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy (2010) (94)
Mechanisms for the Apoptosis of Small Cell Lung Cancer Cells Induced by Anti-GD2 Monoclonal Antibodies (2005) (92)
Gastric MALT Lymphomas Are Divided Into Three Groups Based on Responsiveness to Helicobacter Pylori Eradication and Detection of API2-MALT1 Fusion (2004) (91)
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. (1996) (91)
Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. (2003) (91)
ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection (2011) (90)
β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma (1999) (89)
Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. (1987) (88)
Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. (2001) (86)
Altered imprinting in lung cancer (1994) (86)
A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. (2002) (85)
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer (2010) (84)
Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. (2004) (84)
High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. (2000) (83)
Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22. (1993) (81)
Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. (2007) (78)
The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. (1992) (77)
Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon (1996) (76)
Ontogenic development of T and B cells and non-lymphoid cells in the white pulp of human spleen. (1986) (76)
MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer (2008) (76)
Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the cote d'Ivoire: Complete genome sequence and phylogenetic relatedness of HBV genotype E (2003) (75)
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. (2012) (74)
A case of infantile acute monocytic leukemia caused by vertical transmission of the mother's leukemic cells (1990) (73)
Systematic review and meta‐analysis: importance of CagA status for successful eradication of Helicobacter pylori infection (2006) (72)
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. (2000) (72)
Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis (2005) (72)
Eight genotypes (A–H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics (2004) (71)
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. (2009) (71)
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand (2002) (70)
Genetic abnormalities involved in t(12;21) TEL–AML1 acute lymphoblastic leukemia: Analysis by means of array‐based comparative genomic hybridization (2007) (69)
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. (2006) (69)
The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer. (2007) (68)
Elevation of Anti-Cytokeratin 18 Antibody and Circulating Cytokeratin 18: Anti-Cytokeratin 18 Antibody Immune Complexes in Sera of Patients with Idiopathic Pulmonary Fibrosis (2000) (67)
Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. (2006) (67)
ABO blood group alleles and the risk of pancreatic cancer in a Japanese population (2011) (67)
Three different GB virus C/hepatitis G virus genotypes (1997) (67)
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma (2005) (67)
One‐carbon metabolism‐related gene polymorphisms and risk of head and neck squamous cell carcinoma: Case–control study (2007) (67)
Clinical significance of serum Th1‐, Th2‐ and regulatory T cells‐associated cytokines in adult T‐cell leukemia/lymphoma: High interleukin‐5 and ‐10 levels are significant unfavorable prognostic factors (2006) (66)
Inconsistent association of Epstein‐Barr virus with CD56 (NCAM)‐positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract (1996) (65)
Immunopathogenesis of lymphoma: Focus on CCR4 (2011) (65)
Single clonal origin of neoplastic B‐cells with different immunoglobulin light chains in a patient with Richter's syndrome (1990) (64)
Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. (1986) (64)
Loss of Heterozygosity at the bcl‐2 Gene Locus and Expression of bcl‐2 in Human Gastric and Colorectal Carcinomas (1994) (64)
Selective usage of D-type cyclins in lymphoid malignancies (1999) (63)
Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer. (1994) (63)
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy (2002) (62)
Monoamine oxidase polymorphisms and smoking behaviour in Japanese. (2003) (62)
Growth Inhibition of Multiple Myeloma Cells by a Novel IκB Kinase Inhibitor (2005) (61)
Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique. (1987) (61)
GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. (1996) (61)
Prognostic Implication of FLT 3 and N-RAS Gene Mutations in Acute Myeloid Leukemia (1999) (60)
Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. (1996) (60)
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. (2009) (60)
Malignant lymphoma of mucosa‐associated lymphoid tissue arising in the thymus of a patient with sjögren's syndrome (1992) (60)
DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. (1997) (59)
Effect of dietary antioxidants and risk of oral, pharyngeal and laryngeal squamous cell carcinoma according to smoking and drinking habits (2006) (59)
The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. (2005) (59)
Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. (2003) (59)
Detection of MUM1/IRF4-IgH fusion in multiple myeloma (1999) (59)
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. (2006) (58)
Defucosylated Anti–CC Chemokine Receptor 4 Monoclonal Antibody Combined with Immunomodulatory Cytokines: A Novel Immunotherapy for Aggressive/Refractory Mycosis Fungoides and Sézary Syndrome (2007) (57)
Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines (2000) (57)
Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In Vivo1 (2009) (57)
Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. (2017) (57)
An Anti‐GD2 Monoclonal Antibody Enhances Apoptotic Effects of Anti‐cancer Drugs against Small Cell Lung Cancer Cells via JNK (c‐Jun Terminal Kinase) Activation (2002) (56)
Bortezomib‐induced apoptosis in mature T‐cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl‐1 (2009) (56)
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment. (2018) (56)
Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping (2002) (54)
The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma (2006) (54)
Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. (1994) (54)
Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor. (2007) (54)
Monoclonal Antibody against PRADl/Cyclin Dl Stains Nuclei of Tumor Cells with Translocation or Amplification at BCL‐1 Locus (1994) (53)
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support. (2003) (53)
Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus (2003) (53)
Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma (1994) (52)
In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice (2001) (52)
Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China. (2002) (52)
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma. (2017) (51)
High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors. (1999) (50)
Induction of cell death in adult T-cell leukemia cells by a novel IκB kinase inhibitor (2006) (50)
The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis (2012) (50)
Antibody therapy for Adult T-cell leukemia–lymphoma (2011) (49)
Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies (2017) (49)
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy (2001) (48)
A phenotypic and genotypic study of three node‐based, low‐grade peripheral T‐cell lymphomas: Angioimmunoblastic lymphoma, T‐zone lymphoma, and lymphoepithelioid lymphoma (1992) (48)
Microsatellite instability associated with hepatocarcinogenesis. (1999) (47)
Fatal reactivation of hepatitis B virus infection in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2015) (47)
Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy (2011) (47)
Point Mutations of c‐ras Genes in Human Bladder Cancer and Kidney Cancer (1990) (46)
Phenotypic analysis of peripheral T cell lymphoma among the Japanese (1993) (46)
Serological analysis of cell surface antigens of null cell acute lymphocytic leukemia by mouse monoclonal antibodies. (1982) (45)
Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells (2000) (44)
Molecular Analysis of the Protein Tyrosine Phosphatase γ Gene in Human Lung Cancer Cell Lines (1992) (43)
POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17 (2008) (42)
Sustained activation of c‐jun‐N‐terminal kinase plays a critical role in arsenic trioxide‐induced cell apoptosis in multiple myeloma cell lines (2006) (41)
Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus (1997) (41)
Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation. (1996) (41)
Risk Factors and Seroprevalence of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection in Uzbekistan (2002) (40)
Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma (1999) (40)
Expression of the TCL1 Gene at 14q32 in B‐Cell Malignancies but Not in Adult T‐Cell Leukemia (1998) (40)
bcl‐2 Gene Rearrangement Analysis in Japanese B Cell Lymphoma; Novel bcl‐2 Recombination with Immimoglobulin K Chain Gene (1989) (40)
Clinicopathologic study of 212 cases of peripheral T‐cell lymphoma among the Japanese (1993) (39)
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection (2003) (39)
Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). (1999) (39)
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells (2007) (38)
Immunoglobulin VH gene analysis in gastric MALT lymphomas (2007) (38)
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation (1993) (38)
Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis (2019) (37)
Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidinuria. (1996) (37)
Clinical characteristics and prognostic implications of NPM 1 mutations in acute myeloid leukemia (2005) (36)
Dexamethasone Palmitate Ameliorates Macrophages-Rich Graft-versus-Host Disease by Inhibiting Macrophage Functions (2014) (36)
Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay. (1989) (36)
Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation. (1993) (36)
ABCC11/MRP8 confers pemetrexed resistance in lung cancer (2010) (36)
API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. (2003) (36)
Role of ABCG2 as a biomarker for predicting resistance to CPT‐11/SN‐38 in lung cancer (2006) (36)
Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon‐α therapy for patients with chronic hepatitis C (2005) (36)
The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma (1995) (36)
Transforming growth factor‐beta‐1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection (2003) (35)
A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma. (2006) (35)
A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan (2007) (35)
Differences of Hepatocellular Carcinoma Patients with Hepatitis B Virus Genotypes of Ba, Bj or C in Japan (2005) (35)
Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). (1994) (35)
EBV‐positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases (2019) (35)
Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors. (2009) (35)
Clinical Application of Anti-CCR4 Monoclonal Antibody (2015) (34)
Serum Soluble Interleukin‐2 Receptor Levels in Patients with Adult T‐cell Leukemia and Human T‐cell Leukemia/Lymphoma Virus Type‐I Seropositive Healthy Carriers (1988) (34)
Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. (2005) (34)
Pyogenic granuloma of the stomach successfully treated by endoscopic resection after transarterial embolization of the feeding artery (2005) (34)
A new genotype of TT virus (TTV) infection among Colombian native Indians (1999) (34)
Myofibroblasts and S-100 protein positive cells in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial pneumonia. (1999) (33)
Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. (2005) (33)
Double immunoenzymatic detection of surface phenotype of proliferating lymphocytes in situ with monoclonal antibodies against DNA polymerase alpha and lymphocyte membrane antigens. (1987) (33)
Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity. (1993) (33)
Efficacy of Docetaxel as a Second-Line Chemotherapy for Thymic Carcinoma (2004) (33)
Effect of familial history and smoking on common cancer risks in Japan (2007) (33)
Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma. (2001) (33)
Classifying genotype F of hepatitis B virus into F1 and F2 subtypes. (2005) (33)
Molecular cloning of the chromosomal breakpoint of a B-cell lymphoma with the t(11;14)(q23;q32) translocation. (1991) (33)
Expression of the ULBP ligands for NKG2D by B‐NHL cells plays an important role in determining their susceptibility to rituximab‐induced ADCC (2009) (33)
Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation. (2005) (32)
Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E (2005) (32)
Subcellular localization and protein interaction of the human LIMK2 gene expressing alternative transcripts with tissue-specific regulation. (1996) (32)
Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. (1994) (32)
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809. (2011) (32)
MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B‐Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (2002) (31)
Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80. (1998) (31)
Ectopic expression of c‐kit in small‐cell lung cancer (1994) (31)
Serum glutathione s‐transferase‐π level as a tumor marker for non‐small cell lung cancer. Potential predictive value in chemotherapeutic response (1994) (31)
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients (2018) (31)
Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation (2006) (31)
Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations (1997) (31)
Multiple myeloma preceding the development of chronic myelogenous leukemia. (1999) (30)
Fusion of the MLL gene with two different genes, AF-6 and AF-5alpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia. (1996) (30)
Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. (2004) (30)
Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature (2007) (30)
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study (2012) (30)
Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutated (2006) (29)
Analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with type 2 blood group determinants. (1990) (29)
Alterations of Integrin Expression in Human Lung Cancer (1993) (29)
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy (2015) (29)
Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer. (2007) (29)
Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: Prevalence, associated factors, and impact on quality of life (2010) (29)
Quantitative expression of erythropoietin receptor (EPO‐R) on acute leukaemia cells: relationships between the amount of EPO‐R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis (2000) (29)
Reactivation of hepatitis B virus in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2014) (28)
The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan (2003) (28)
Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania (2006) (28)
Multistep Tumorigenesis of Multiple Myeloma: Its Molecular Delineation (2003) (28)
Overexpression of carboxylesterase‐2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT‐11), for multiple myeloma (2008) (28)
Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. (2011) (28)
Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma (2017) (28)
A retrospective study of the epidemiology of Clostridiumdifficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients (2010) (27)
Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. (2005) (27)
Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii. (2004) (27)
The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan. (2003) (27)
Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma (2003) (27)
The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia. (2002) (27)
Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia (1997) (27)
Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma. (2014) (27)
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines (2008) (27)
Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF (2008) (27)
Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis (2005) (26)
Microscopic polyangiitis associated with diffuse panbronchiolitis. (2004) (26)
Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization. (2003) (26)
Clonal T cell population in angioimmunoblastic lymphadenopathy and related lesions. (1987) (26)
Tax is a potential molecular target for immunotherapy of adult T‐cell leukemia/lymphoma (2012) (26)
GB virus C/hepatitis G virus infection among Colombian native Indians. (1998) (25)
Diffuse Large B-Cell Lymphoma With Extra Bcl-2 Gene Signals Detected by FISH Analysis Is Associated With a “Non-Germinal Center Phenotype” (2005) (25)
Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. (2004) (25)
Five antigens on human T cells detected by mouse monoclonal antibodies. (1984) (25)
Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers (2006) (25)
Molecular Cloning of 19p13 Breakpoint Region in Infantile Leukemia with t(11;19)(q23;p13) Translocation (1993) (25)
Ki-1 (CD30) positive anaplastic large cell lymphoma of T-cell phenotype developing in association with long-standing tuberculous pyothorax: report of a case with detection of Epstein-Barr virus genome in the tumor cells. (1995) (25)
Prognostic significance of CD44v6 in diffuse large B-cell lymphoma. (1999) (25)
Aggressive rectal lymphoma of large granular lymphocytes with the histologic feature of an angiocentric growth pattern (1993) (25)
Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis (2014) (24)
A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load. (2004) (24)
Molecular-cytogenetic Characterization of Non-Hodgkin's Lymphoma with Double and Cryptic Translocations of the Immunoglobulin Heavy Chain Gene (2004) (23)
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study. (2020) (23)
Transduction of a Drug-Sensitive Toxic Gene into Human Leukemia Cell Lines with a Novel Retroviral Vector (1993) (23)
Current status of immunotherapy. (2016) (23)
Novel Hepatitis B Virus Genotype A Subtyping Assay That Distinguishes Subtype Aa from Ae and Its Application in Epidemiological Studies (2004) (23)
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]. (2015) (22)
Feed-forward Regulatory Loop Driven by IRF4 and NF-κB in Adult T-cell Leukemia/Lymphoma. (2020) (22)
Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells. (1985) (21)
Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis (2009) (21)
Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma. (1999) (21)
Multiple Myeloma Oncogene 1 (MUM1)/Interferon Regulatory Factor 4 (IRF4) Upregulates Monokine Induced by Interferon-gamma (MIG) Gene Expression in B-Cell Malignancy. (2004) (21)
Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine (2008) (21)
Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong. (1995) (21)
Heterogeneity in E2 region of GBV‐C/hepatitis G virus and hepatitis C virus (1998) (21)
A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells (1996) (21)
Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma-linked chromosomal translocation junction gene on 11q23. (1995) (21)
Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. (2003) (20)
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports (2010) (20)
Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell–Bearing NOD/Shi-scid, IL-2Rγnull Mouse Model (2013) (20)
bcl‐2 Translocation in Japanese B Cell Lyraphoma: Novel bcl‐2 Translocation with Immunoglobulin Heavy Chain Diversity Segment (1991) (20)
Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line. (1988) (20)
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma (2015) (20)
Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. (1991) (20)
Detection of chimeric mRNAs by reverse transcriptase-polymerase chain reaction for diagnosis and monitoring of acute leukemias with 11q23 abnormalities. (1997) (20)
Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-γ (MIG) gene expression in B-cell malignancy (2005) (19)
Follow‐up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: impact on allogeneic haematopoietic stem cell transplantation (2019) (19)
Clinicopathologic study of primary mediastinal non‐lymphoblastic non‐Hodgkin's lymphomas among the Japanese (1993) (19)
Radioimmunoscintigraphy of Intracranial Glioma Xenograft with a Technetium-99m-Labeled Mouse Monoclonal Antibody Specifically Recognizing Type III Mutant Epidermal Growth Factor Receptor (2003) (19)
Comparison of [3H]glucosamine-labeled glycoproteins from human renal cancer and normal kidney epithelial cell cultures by two-dimensional polyacrylamide gel electrophoresis. (1981) (19)
Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. (2008) (19)
Idiopathic CD4+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient. (1997) (19)
Expression of chemokine receptors CXCR3 and CCR4 in lymphocytes of idiopathic nonspecific interstitial pneumonia. (2007) (19)
Human Cancer Immunology (1980) (18)
p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis (2005) (18)
Expression of CD44 Variant Isoforms in Normal and Neoplastic Cells of the Lung (1994) (18)
In vitro and in vivo properties of human/mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. (1990) (18)
Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7. (1996) (18)
HTLV-1 bZIP Factor–Specific CD4 T Cell Responses in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation (2014) (18)
The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer. (2014) (18)
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus‐related chronic liver disease (2004) (18)
Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer. (1986) (18)
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma (2018) (18)
Mouse monoclonal antibodies detecting disialogangliosides on mouse and human t lymphomas (1988) (18)
Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement. (1993) (18)
Distribution of adenosine deaminase binding protein in normal and malignant tissues of the gastrointestinal tract studied by monoclonal antibodies (1993) (18)
11q23 Aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone (1996) (17)
Extragonadal germ cell tumors in Japan (2003) (17)
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR) (2005) (17)
Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique. (1986) (17)
Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions (2016) (17)
Clinical significance of tryptophan catabolism in Hodgkin lymphoma (2017) (17)
Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases (2001) (17)
Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers (2020) (17)
Multicenter Phase II Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, In Relapsed Patients with Adult T-Cell Leukemia-Lymphoma (ATL) (2010) (17)
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγnull mouse lymphoma model (2010) (16)
Reactivity of a Monoclonal Antibody Raised against Human Leukemic Cells to Embryonic and Adult Tissues of the Mouse and Teratocarcinomas (1983) (16)
High prevalence and phylogenetic analysis of TT-virus infection in Mongolia. (1999) (16)
Inappropriate use of loperamide worsens Clostridium difficile-associated diarrhoea. (2008) (16)
Primary mucosa‐associated lymphoid tissue lymphoma of the prostate: Tumor relapse 7 years after local therapy (2008) (16)
Human T‐cell lymphotropic/leukemia virus type 1 (HTLV‐1) Tax‐specific T‐cell exhaustion in HTLV‐1‐infected individuals (2018) (16)
GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24) (2001) (16)
Angioimmunoblastic T-cell lymphoma mice model. (2013) (15)
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma. (2020) (15)
Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma (2021) (15)
Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia (1999) (15)
Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection. (1996) (15)
Molecular evolutionary analysis of the complete nucleotide sequence of hepatitis B virus (HBV) in a case of HBV infection acquired through a needlestick accident. (2000) (15)
Rearrangement of bcl‐2 genes in malignant lymphomas in chinese patients (1993) (15)
Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, Am80, after relapse from CR induced by all-trans-retinoic acid. (2000) (15)
Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL). (2013) (15)
Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. (1997) (15)
Detection of Adult T‐Cell Leukemia Virus (ATLV) Bearing Lymphocytes in Concentrated Red Blood Cells Derived from ATL Associated Antibody (ATLA‐Ab) Positive Donors (1986) (15)
Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy (2002) (14)
Genotype of GB virus C/hepatitis G virus by molecular evolutionary analysis. (1997) (14)
Histopathological investigation of salivary glands in the asymptomatic elderly. (2004) (14)
Spontaneous hepatic rupture due to metastatic tumor of lung adenocarcinoma. (2005) (14)
TT virus infection among IVDUs in south western China. (1999) (14)
A case of neural cell adhesion molecule-positive peripheral T-cell lymphoma associated with human T-cell lymphotrophic virus type 1 showing an unusual involvement of the gastrointestinal tract during the course of the disease. (1994) (14)
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial. (1999) (14)
Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. (1988) (13)
Genuine CD7 expression in acute leukemia and lymphoblastic lymphoma. (1990) (13)
Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter. (1983) (13)
An immunohistologic study of the epithelial components of 81 cases of thymoma (1992) (13)
Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus--virological response of HGV and pretreatment HGV viremia level. (1997) (13)
Synchronous lung cancer presenting with small cell carcinoma and adenocarcinoma. (1993) (13)
Molecular analysis of the protein tyrosine phosphatase gamma gene in human lung cancer cell lines. (1992) (13)
Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22). (2002) (13)
Analysis of β-tubulin gene alteration in human lung cancer cell lines (2003) (13)
Rapid analysis of Clostridium difficile strains recovered from hospitalized patients by using the slpA sequence typing system (2009) (13)
High prevalence of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan. (1997) (13)
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies (1997) (12)
Modification of chemo-radiosensitivity of a human lung cancer cell line by introduction of the glutathione S-transferase pi gene. (1996) (12)
Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer (1992) (12)
Isolation of a novel cDNA clone showing marked similarity to ME491/CD63 superfamily (2004) (12)
Transient appearance of CD3+CD8+ T lymphocytes with monoclonal gene rearrangement of T‐cell receptor β locus (1998) (12)
Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide? (1994) (12)
Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases (2006) (12)
Lack of Ku80 Alteration in Multiple Myeloma (2002) (12)
Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis. (2012) (12)
Lack of Integrated TT Virus (TTV) Genomes Into Cellular DNA in Infected Human Hematopoietic Cells (2000) (12)
Chromosomal assignments of genes coding for human leukocyte common antigen, T-200, and lymphocyte function-associated antigen 1, LFA-1β subunit (1987) (12)
Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma (2007) (12)
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma. (2013) (12)
Clinical significance of CD28 gene‐related activating alterations in adult T‐cell leukaemia/lymphoma (2020) (12)
MRP 7 / ABCC 10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer (2008) (12)
Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling. (2018) (12)
Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue. (1994) (12)
Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. (2003) (11)
Parental origin of 11p15 deletions in human lung cancer. (1994) (11)
Comparison of multiple rosetting assays for detecting antibody reactivity of different immunoglobulin classes against surface antigens of benign and malignant tissue culture cells. (1980) (11)
Hepatic Fas Protein Expression Might Be a Predictive Factor for Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis C Undergoing Interferon Therapy (2002) (11)
Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy. (2011) (11)
Isolation and characterization of mouse CD7 cDNA (2004) (11)
Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model (2012) (11)
Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. (2004) (11)
Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia. (1998) (11)
Assignment of gene coding human T-cell differentiation antigen, Tpl20, to chromosome 11 (1985) (11)
Characterization of a kidney antigen defined by a mouse monoclonal antibody K2.7. (1987) (11)
Immunohistological analysis of thymic tumors with PE-35 monoclonal antibody reactive with medullary thymic epithelium. (1988) (11)
Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus (2003) (11)
Normotensive scleroderma renal crisis with diffuse alveolar damage after corticosteroid therapy (2005) (11)
Antitumor Impact of p14ARF on Gefitinib-Resistant Non–Small Cell Lung Cancers (2013) (11)
Hepatitis B virus genotype G is an extremely rare genotype in Japan. (2004) (11)
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma (2019) (11)
Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. (1985) (11)
Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjögren’s syndrome (2004) (11)
Microsatellite instability is rare in the clinical course of myelodysplastic syndrome studied with DNA from fresh and paraffin-embedded tissues (1998) (10)
Drug-induced hypersensitivity syndrome associated with a marked increase in anti-paramyxovirus antibody titers in a scleroderma patient. (2007) (10)
GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze river, China (1998) (10)
Ganglioside GD 2 in Small Cell Lung Cancer Cell Lines : Enhancement of Cell Proliferation and Mediation of Apoptosis 1 (2001) (10)
Over one‐third of African‐American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg‐7, an autosomal dominantly inherited risk factor for MGUS/MM (2014) (10)
Assignment of a gene coding for a human T-cell antigen with a molecular weight of 40,000 daltons to chromosome 17. (1988) (10)
Case-control study of leukemia and diagnostic radiation exposure. (1997) (10)
Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma (2021) (10)
[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan]. (2005) (10)
Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides. (2013) (10)
Serodiagnosis of Mycobacterium avium-complex pulmonary disease with an enzyme immunoassay kit that detects anti-glycopeptidolipid core antigen IgA antibodies in patients with rheumatoid arthritis (2011) (10)
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study (2009) (9)
Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies. (1991) (9)
A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene. (2003) (9)
ABCC 10 / MRP 7 is associated with vinorelbine resistance in non-small cell lung cancer (9)
Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. (2012) (9)
Identification of Three Novel Chromosomal Translocation Partners Involving the Immunoglobulin Loci in Newly Diagnosed Myeloma and Human Myeloma Cell Lines. (2005) (9)
Lack of association between TTV viral load and aminotransferase levels in patients with hepatitis C or non-B-C. (2000) (9)
Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti‐liver/kidney microsome autoantibody type 1 (2001) (9)
Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma (2018) (9)
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia (2003) (9)
Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. (2009) (9)
Efficacy of S-1 monotherapy for non-small cell lung cancer after the failure of two or more prior chemotherapy regimens. (2010) (8)
Enterovesical fistula complication in B-cell-type lymphoma of the small intestine (2004) (8)
Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myeloma. (2005) (8)
Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma (2004) (8)
Pregnancy among long-term survivors of acute leukemia. A second nationwide survey. (1998) (8)
Isolation of stable mouse L cell transfectant expressing human T cell differentiation antigen, Tp40. (1985) (8)
Amrubicin monotherapy for elderly patients with previously treated lung cancer. (2010) (8)
T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia (2003) (8)
Distribution of JC virus DNA in peripheral blood lymphocytes of hematological disease cases. (1999) (7)
[Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report]. (1997) (7)
Prevalence of TT Virus and GBV-C Infections among Patients with Liver Diseases and the General Population in Shanghai, China (2004) (7)
Combining T‐cell‐based immunotherapy with venetoclax elicits synergistic cytotoxicity to B‐cell lines in vitro (2020) (7)
Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class. (1986) (7)
Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112. (2011) (7)
Biological and clinical significance of the FLT 3 transcript level in acute myeloid leukemia (2003) (7)
2015 Guidance on cancer immunotherapy development in early‐phase clinical studies (2015) (7)
Expression of neural cell adhesion molecule in normal gastric mucosa and in gastric carcinoid tumors. (1994) (7)
The Interaction of Recombinant IL‐2 with Human Resting Lymphocytes (1987) (7)
Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma (2020) (7)
Production and characterization of an active single-chain variable fragment antibody recognizing CD25. (2005) (7)
Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids (2002) (7)
Phase I Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, in Relapsed Patients (Pts) with Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL): Updated Results. (2008) (7)
Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy? (2013) (7)
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study (2017) (6)
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma (2022) (6)
Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy (2021) (6)
Novel Interleukin‐2 Dependent T‐Cell Line Derived from Adult T‐Cell Leukemia Not Associated with Human T‐Cell Leukemia Virus Type I (1993) (6)
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL) (2011) (6)
CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival (2019) (6)
CD34+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications (2001) (6)
Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells (2015) (6)
Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. (1985) (6)
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors (2021) (6)
Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue disease. (2007) (6)
Clinical Significance of CCR 4 Expression in Adult T-Cell Leukemia / Lymphoma : Its Close Association with Skin Involvement and Unfavorable Outcome 1 (2003) (6)
T cell receptor beta chain gene rearrangements in leukemias with immature T cell phenotype. (1986) (6)
Liver Transplantation-Associated de novo Hepatitis B Virus Infection: Application of Molecular Evolutionary Analysis (2002) (6)
Risk of Japanese carriers of hyperphosphorylated paratarg‐7, the first autosomal‐dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma (2011) (6)
Peripheral T‐cell Lymphoma of AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) Type Involving Gastrointestinal Tract (1992) (6)
Angioimmunoblastic T‐cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]‐type T‐cell lymphoma) followed by Hodgkin's disease associated with Epstein‐Barr virus (1995) (6)
Phase 1/2 study of forodesine in patients with relapsed peripheral t-cell lymphoma (PTCL). (2016) (6)
Characterization of three mouse monoclonal antibodies that react with high-molecular-mass glycopeptides isolated from F9 mouse teratocarcinoma cells. (1986) (6)
Cryptogenic organizing pneumonia after radiotherapy for breast cancer (2005) (6)
Variations in the Viral NS5B Region in Japanese Patients with Chronic Hepatitis C Virus Genotype 1b Infection (2006) (6)
Current state of therapeutic development for rare cancers in Japan, and proposals for improvement (2018) (6)
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma (2021) (5)
Chapter 24 Serological and biochemical analysis of four antigens associated with small cell lung cancer (1988) (5)
Antitumor effects of bevacizumab in a microenvironment‐dependent human adult T‐cell leukemia/lymphoma mouse model (2014) (5)
p185HER‐2/neu and p21CIP1/WAF1 Expression in Primary Tumors and Lymph Node Metastases in Non‐small Cell Lung Cancer (2002) (5)
A Human Monoclonal Antibody Recognizing a Surface Antigen on Stomach Cancer Cells (1989) (5)
Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans (1998) (5)
Establishment and characterization of a novel vincristine‐resistant diffuse large B‐cell lymphoma cell line containing the 8q24 homogeneously staining region (2018) (5)
Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. (2000) (5)
Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705) (2013) (5)
In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomes (2020) (5)
Pulmonary AL amyloidosis in a patient with primary Sjögren syndrome (2002) (5)
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid. (2007) (5)
Two monoclonal antibodies detecting allotypic determinants of HLA-A. (2008) (5)
A study on intraalveolar exudates in acute mycoplasma pneumoniae infection. (2002) (5)
A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system. (2011) (5)
Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias. (1997) (5)
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group. (1997) (4)
[A case of Behçet disease with multiple nodular shadows and aneurysm of the brachiocephalic trunk caused by necrotizing vasculitis]. (2006) (4)
Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy (1999) (4)
Interdigitating cell sarcoma (ICS): Additional findings of ICS and evidence of interdigitating cell origin, immunocytochemical studies with monoclonal anti-ICS antibodies. (1989) (4)
[A case of sarcoidosis with rheumatic features (Löfgren's syndrome)]. (2003) (4)
Phenotypic and Genotypic Lineage Switch of a Lymphoma with Shared Chromosome Translocation and T‐Cell Receptor γ Gene Rearrangement (1992) (4)
Analysis of beta-tubulin gene alteration in human lung cancer cell lines. (2003) (4)
Mediastinal diffuse large cell lymphoma of B-cell type with azurophilic granules. (1992) (4)
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia (2021) (4)
Inactivation of Multiple Tumor-Suppressor Genes Involved in Negative Regulation of the CellCycle , MTSlip 16 ' NK 4 A / CDKN 2 , MTS 2 / plSXNKTB , p 53 , and Rb Genes in Primary Lymphoid Malignancies (2002) (4)
Tumor-specific antigens. (1980) (4)
Translocation (9;11;22)(p22;q23;q11). A new type of complex variant translocation of t(9;11)(p22;q23) with MLL rearrangement. (1996) (4)
Phase I Study of KW-0761, a Humanized Anti-CCR4 Antibody, in Patients (Pts) with Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATLL) and Peripheral T-Cell Lymphoma (PTCL): Preliminary Results. (2007) (4)
Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection (2010) (4)
Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus‐positive hepatocellular carcinoma (2007) (4)
[Changes in erythrocyte structure and in platelets in elderly patients with disseminated intravascular coagulation]. (1996) (4)
Differential prognosis detected by immunophenotyping in acute lymphoblastic leukemia of childhood with poor prognostic factors. (1987) (4)
Identification of myeloid origin in undifferentiated congenital leukemia by in vitro marrow culture study. (1989) (4)
A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein. (2000) (4)
Lineage Conversion From Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia on Rearrangement of the IgH Gene in a Patient with Down Syndrome (2002) (3)
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma (2012) (3)
Clinical significance of tryptophan catabolism in follicular lymphoma (2020) (3)
Gene encoding human p250 T-cell activation antigen maps to human chromosome 11 (1988) (3)
Prophylactic antiviral therapy for HBsAg-positive patients with DLBCL treated with rituximab-containing chemotherapy. (2021) (3)
Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab (2021) (3)
Myofibroblasts proliferation of idiopathic and collagen vascular disorders associated nonspecific interstitial pneumonia. (2003) (3)
Advances in Brief p 53 Mutations in Non-Small Cell Lung Cancer in Japan : Association between Mutations and Smoking 1 (2006) (3)
Human glioma associated and related antigens, identified by monoclonal antibodies (2005) (3)
Clonality Assay of Hematopoietic Disorders: Significance of the Buccal Epithelium as Non‐hematopoietic Control and of 95% Rejection Limit as a Novel Criterion for Monoclonality (2001) (3)
Reply to R. Suzuki (2010) (3)
[Recurrence of thymoma accompanied with hypogammaglobulinemia 20 years after surgery: a case report]. (2002) (3)
Expression of the ULBP Ligands for NKG2D by B-NHL Cells Plays An Important Role in Determining Their Susceptibility to Rituximab-Induced ADCC (2008) (3)
Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule (2002) (3)
Molecular cloning of the gene coding for the human T cell differentiation antigen CD7 (2004) (3)
Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism. (1990) (3)
Interdigitating cell sarcoma (ICS) (1989) (3)
Analysis of conserved ambisense sequences within GB virus C. (1998) (3)
In vivo andin vitro antitumor activity of mitomycin C conjugates at 7-N position through a linker containing thiocarbamate bond with CD10 monoclonal antibody (1992) (3)
Long-term follow-up of 14 patients with philadelphia chromosome—positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission (2007) (3)
Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) (2016) (3)
Successful treatment of reactive hemophagocytic syndrome by plasmapheresis and high-dose γ-globulin in a patient with systemic lupus erythematosus (2000) (2)
Multiple myeloma with infiltration into skeletal muscle after injections of granulocyte‐colony stimulating factors (2004) (2)
P-Glycoprotein Is Related to the Achievement of Complete Remission but Not to Disease-Free Survival in Adult Acute Lymphoblastic Leukemia: A Prospective Analysis in the JALSG-ALL97 Study. (2004) (2)
CD7 Expression in Malignant Pleural Mesothelioma (1992) (2)
In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients (2022) (2)
Seroprevalence ofHelicobacter pylori and association with atrophic gastritis in patients with Sjögren’s syndrome (1999) (2)
Effects of FOXP3 gene polymorphism in sarcoidosis patients. (2007) (2)
CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment (2022) (2)
Tumor‐infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma (2021) (2)
Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab (2021) (2)
Clinical significance of the soluble interleukin‐2 receptor as a putative systemic nutritional index in the elderly * (2004) (2)
[Adenocarcinoma of the lung with skeletal muscle metastasis, resulting in death due to myocardial metastasis: a case report]. (2002) (2)
Further investigation of the epitope recognized by the new monoclonal antibody 2C9 (2003) (2)
[A case of spinal osteomyelitis due to Mycobacterium intracellulare with pulmonary Mycobacterium avium complex]. (2010) (2)
[A patient with mediastinal liposarcoma showing dedifferentiation]. (2002) (2)
Usefulness of uracil loading test for detecting 5-fluorouracil metabolic enzyme deficiencies in humans (2000) (2)
Detection of Locally Recurrent Colorectal Cancer with Radiolabeled Monoclonal Antibody H‐15 (1992) (2)
Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma (2021) (2)
In vitro effects of a recombinant toxin, mSCF-PE40, targeting c-kit receptors ectopically expressed in small cell lung cancers. (1997) (2)
[Therapy-related leukemia and myelodysplastic syndrome: a multi-institution study in Japan]. (1998) (2)
Nuclear localization of antigens detected by a monoclonal antibody against a synthetic peptide of rfp finger protein. (1990) (2)
Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy. (1999) (1)
Abstract 3961: Increased CCR4-positive regulatory T cells in biopsy specimen of poor prognosis prostate cancer (2017) (1)
Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab‐containing chemotherapy (2014) (1)
Progression from myelodysplastic syndrome with monosomy 7 to acute monoblastic leukemia with MLL gene rearrangement. (1998) (1)
Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia (2022) (1)
[Successful use of immunosuppressive agents for the treatment of progressive rheumatoid interstitial lung disease: a case report]. (2002) (1)
TGFB1 mRNA expression is associated with poor prognosis and specific features of inflammation in ccRCC (2022) (1)
The Clinical and Biological Effects of PD-1 Expression on Tumor Cells in Diffuse Large B-Cell Lymphoma (2021) (1)
Establishment and Characterization of a Novel Human Myeloma Cell Line, AMU-MM1, From a Multiple Myeloma Patient Involving Central Nerve System After Treatment with Bortezomib (2010) (1)
In vivo and in vitro antitumor activity of mitomycin C conjugates at 7N position through a linker containing thiocarbamate bond with CD 10 monoclonal antibody (1)
The 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium "challenges in cancer metastasis", 11-12 September 1998, Nagoya, Japan (1999) (1)
Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up (2003) (1)
Risk factors of disseminated intravascular coagulation in septic systemic inflammatory response syndrome in nursing home residents (2006) (1)
[A case of bacteria-associated hemophagocytic syndrome induced by nosocomial pneumonia]. (2003) (1)
Synergistic Effect of Venetoclax for Antibody Dependent Cell Cytotoxicity By Daratumumab (2020) (1)
[Anti-CCR4 monoclonal antibody as a novel therapy for advanced mycosis fungoides and Sézary syndrome]. (2009) (1)
A Variant Chromosome Translocation at l l q 1 3 Identifying PRADIICyclin D l as the BCL-I Gene (2002) (1)
Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines (2020) (1)
CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma (2019) (1)
GB virus C/hepatitis G virus infection among Japanese patients with hematological diseases (1997) (1)
Screening of Monoclonal Antibodies against T Cell Differentiation Antigens Using Transfectants or Somatic Cell Hybrids (1986) (1)
P2.07-015 Reviving Chemotherapy Sensitivity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients (2017) (1)
Progress in Clinical Use of CC Chemokine Receptor 4 Antibody for Regulatory T Cell Suppression (2015) (1)
[Molecular approach to lung cancer]. (1995) (1)
Upregulation of the Chemokine Receptor CCR4 in Cutaneous T-Cell Lymphoma and Nodal T-Cell Lymphoma: Implications for Targeted Therapy. (2004) (1)
Molecular cloning of the gene coding for the mouse T-cell antigen CD7 (2004) (1)
[Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation]. (1992) (1)
ABT-199 (venetoclax) Synergizes Cytotoxicity of Cytotoxic T-Cell (CTL) to B-Cell Lymphomas (2018) (1)
[A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide]. (2005) (1)
Increased CCR4-positive regulatory T cells in biopsy specimens of poor prognostic prostate cancer (2017) (1)
Abstract A033: Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients (2016) (1)
Acute GB virus C/hepatitis G virus hepatitis preceding aplastic anemia (1997) (1)
Updated Report of a Phase I/II Multicenter Study of Forodesine, a Purine Nucleoside Phosphorylase Inhibitor, in Japanese Patients with Relapsed Peripheral T-Cell Lymphoma (2017) (1)
Characterization of OM‐B Monoclonal Antibody‐defined Antigen Associated with Mucinous Type Human Ovarian Tumor (1993) (1)
Overexpression of Carboxylesterase-2 Results in Enhanced Efficacy of Topoisomerase I Inhibitor, Irinotecan (CPT-11), for Refractory Multiple Myeloma. (2006) (1)
Immunological Classification of Leukemias with Monoclonal Antibodies (1984) (1)
[BCL-2 gene in lymphocytic malignancy]. (1991) (1)
Clinical Significance of Serum TARC/CCL17 in ATLL Patients: High TARC/CCL17 Level Is a Significant Unfavorable Prognostic Factor (2008) (1)
[CD5- CD11c+ CD23- small lymphocytic lymphoma evolving from aplastic anemia]. (2004) (1)
Mutation in the Box a Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Genotype C Infection (2005) (1)
De Novo CD5+ Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients. (2007) (1)
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma (2018) (1)
Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease. (2023) (1)
[Analysis of cell surface antigen of kidney cancer by autologous sera and monoclonal antibodies]. (1983) (0)
Advances in Brief In Vivo Occurrence of pl 6 ( MTS 1 ) and pl 5 ( MTS 2 ) Alterations Preferentially in Non-Small Cell Lung Cancers 1 (2006) (0)
Eight Months-Complete Remission in a Case of Erythroleukemia Treated with Intensive Chemotherapy, Isogeneic Bone Marrow Graft and Active Immunotherapy (1976) (0)
Establishment of a Novel DLBCL Cell Line: AMU-ML2, Derived from a Primary Refractory Patient Shows Homogeneous Staining Region of 8q24 Inducing High Expression of Long Non-Coding RNAs Encoded By PVT1 and Resistance to Vincristine (2016) (0)
Differences between Japan and rest of world (ROW) in disease presentation and outcome of previously treated adult t-cell leukemia-lymphoma (ATL) using therapy with a monoclonal antibody to CCR4, mogamulizumab (moga). (2016) (0)
A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3 (1992) (0)
Human renal cancer cell surface antigens defined by mouse monoclon- al antibodies. Abstr. (1981) (0)
ComplexIntrachromosomal Rearrangement intheProcess of Amplification oftheL-mycGeneinSmall-Cell LungCancer (1992) (0)
Advances in Brief Messenger RNA Levels of Five Genes Located at Chromosome l lq13 in B-Cell Tumors with Chromosome Translocation t(ll;14)(q13;q32) 1 (2007) (0)
O1–066A MULTICENTER PHASE II STUDY OF MOGAMULIZUMAB (KW-0761) IN PATIENTS WITH RELAPSED PERIPHERAL OR CUTANEOUS T-CELL LYMPHOMA (2013) (0)
[Chemotherapy based on EBM in the field of hematological malignancies]. (2000) (0)
[Molecular diagnosis of leukemia and lymphoma]. (1994) (0)
Immunohistological Analysis of Thymic Tumors with PE-35 Reactive with Medullary Thymic Epithelium1 (2006) (0)
[Tumor markers in malignant lymphoma]. (2002) (0)
Small Cell Lung Cancer Protooncogene Transcripts in kit Preferential Expression of c-Updated Version (2006) (0)
A case of chronic HCV-positive hepatitis who was thought to suppress HCC recurrence after treated with percutaneous radiofrequency ablation against post-operative HCC recurrence, followed by interferon therapy, resulting in sustained-complete response (2004) (0)
Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus (1999) (0)
Asn 505 Mutation of the C-MPL Gene, A Cause of Familial Essential Thrombocythemia, Induces the Autonomous Homodimerizaton of the C-Mpl Independent of Ligand Stimulation. (2004) (0)
Diffuse Large B-Cell Lymphoma with Extra BCL-2 Gene Signals Detected by FISH Analysis Is Associated with “Non-Germinal Center Phenotype” Defined by Immnohistochemistry. (2004) (0)
Distinct Hematolymphoid Disease Entity Myeloid/Natural Killer Cell Precursor Acute Leukemia: A + and CD56 + CD7 (2011) (0)
CTL functions in in vitro experiments using cytomegalovirus (CMV) pp65 antigen-specific CTLs (CMVpp65-CTLs) and oral squamous cell cancer (OSCC) cell lines overexpressing CMVpp65 antigen as target cells. Although CDDP partially inhibited proliferation of memory CMVpp65-CTL in periph- eral blood, the (2017) (0)
Identification of Super-Enhancer-Associated Cancer Genes Provides Novel Therapeutic Targets in Adult T-Cell Leukemia/Lymphoma (2016) (0)
A Novel Cell Line (NCU-L-1) from a Patient with Acute Lymphoblastic Leukemia, FAB, L3, Burkitt's Type. (1990) (0)
p53, and Rb genes in primary lymphoid malignancies regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, Inactivation of multiple tumor-suppressor genes involved in negative (2011) (0)
[Monoclonal antibody for cancer treatment]. (2002) (0)
Clinicopathological study of peripheral T-cell lymphoma among the Japanese. (1990) (0)
Messenger RNA Levels of Five Genes Located at Chromosome l lq 13 in B-Cell Tumors with Chromosome Translocation t ( ll ; 14 ) ( q 13 ; q 32 ) 1 (2007) (0)
[Monoclonal antibodies for the diagnosis of non-Hodgkin's lymphoma and lymphatic leukemia]. (1983) (0)
CANCER DEFINED BY AUTOLOGOUS TYPING (1979) (0)
Investigation of health-related quality of life in patients with Fabry disease in Japan (2010) (0)
Monitoring of Adult T-Cell Leukemia-Lymphoma Cells in Patients Receiving Mogamulizumab, a Humanized Anti-CCR4 Monoclonal Antibody, Using T-Cell Receptor Repertoire Analysis (2016) (0)
[Serological and immunomolecular markers for the diagnosis of hematopoietic tumors]. (1987) (0)
Epidemiological and clinical diffeences between hepatitis B virus genotype B with and without recombination with genotype C (2003) (0)
Association of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, with MGUS and multiple myeloma in different ethnic groups. (2010) (0)
P3–010TESTICULAR AND LEPTOMENINGEAL RELAPSE AS MYELOID SARCOMA IN A PATIENT INITIALLY DIAGNOSED WITH T LYMPHOBLASTIC LYMPHOMA (2013) (0)
Phenotypic analysis of peripheral T-cell lymphoma among theJapanese. (1991) (0)
Styrene Maleic Acid Neocarzinostain-Transcatheter Arterial Embolization for Hepatocellular Carcinoma (1998) (0)
[Clinical significance of soluble interleukin-2 receptor as a putative systemic nutritional index in the elderly]. (2002) (0)
Prognostic Signi fi cance of Tryptophan Catabolism in Adult T-cell Leukemia / Lymphoma (2015) (0)
Allogeneic Hematopoietic Stem Cell Leukemia / Lymphoma Patients after Responses in Adult T Cell Specific CD 4 T Cell − HTLV-1 bZIP Factor (2013) (0)
642 Outbreak of hepatitis C virus infection through contaminated fibrinogen concentrates in Japan-tracing the source by molecular evolutionary analysis (2003) (0)
Abstract 2571: The predictive biomarker for the resistance to antifolate (2010) (0)
Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens (2023) (0)
Effects of olopatadine in limited scleroderma with peripheral eosinophils (2008) (0)
[A case of lymphoblastic crisis in chronic myelogenous leukemia showing pre-T cell phenotype]. (1985) (0)
Establishment and Characterization of Bortezomib-Resistant Myeloma Cell Lines: A Possible Role of Mutated Proteasome β5 Subunit in Preventing the Accumulation of Unfolded Protein, Which Is Otherwise Followed by Catastrophic Endoplasmic Reticulum (ER) Stress. (2009) (0)
[A case of T-cell lymphoblastic lymphoma with multiple patchy shadows in both lung fields]. (2011) (0)
Clinical Significance of Serum Th1-, Th2- and Regulatory T Cells-Associated Cytokines in Adult T-Cell Leukemia/Lymphoma: High Interleukin-5 and -10 Levels Are Significant Unfavorable Prognostic Factors. (2005) (0)
A novel heterozygous germline mutation of NBS1 leading to loss of the MRE11-binding domain predisposes to common types of cancers: A6-02 (2007) (0)
Establishment of An Angioimmunoblastic T-Cell Lymphoma (AITL) Model in the NOG Mouse (2011) (0)
Subject Index Vol. 44, 2001 (2002) (0)
Advances in Brief Rearrangements on Chromosome Ilq 23 in Hematopoietic Tumor-associated t ( ll ; 14 ) and t ( ll ; 19 ) Translocations 1 (2006) (0)
Clinicopathologic study of malignant lymphoma immunohistochemically showing cyclin D1 protein overexpression with special reference to mantle cell lymphoma (1995) (0)
Amylase-Producing Myeloma Cells Reduced Sensitivity to Dexamethasone and Bortezomib. (2014) (0)
Abstract 5487: Identification of super-enhancer-associated cancer genes provides novel therapeutic targets in adult T-cell leukemia/lymphoma (2017) (0)
A Rare Case of Endobronchial Metastasis From Thyroid Cancer (2005) (0)
[Subclassification of acute leukemia and monoclonal antibodies]. (1983) (0)
Mutational Analysis of Thrombopietin, c-MPL and Jak2 Genes in Essential Thrombothethymia Patients - Identification of Concurrent Mutations of c-MPL and Jak2. (2007) (0)
[Myelodysplastic syndrome developed in a mother and her son whose bone marrow karyotype showed monosomy 7]. (1996) (0)
1177 Predicting relapse after cessation of lamivudine monotherapy for chronic hepatitis B virus infection-application of newly developed HBV real-time detection direct test (2003) (0)
A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study (2008) (0)
Scientific category: Immunobiology Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma (2016) (0)
Diagnostics et therapeutiques pour la pneumonie interstitielle (2003) (0)
A Novel Treatment Strategy for Advanced Lacrimal Sac Carcinomas Confirmed by p16 Immunostaining (2021) (0)
Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma (2022) (0)
Subject Index Vol. 50, 2004 (2004) (0)
[Guideline for proper use of antineoplastic agents. Hematopoietic tumors]. (2002) (0)
Improvement of Splenomegaly and Pancytopenia by Enzyme Replacement Therapy Against Type 1 Gaucher Disease: A Report of Sibling Cases (2001) (0)
[New directions for the use of monoclonal antibodies in leukemia diagnosis and therapy]. (1986) (0)
Author response for "Combining T‐cell‐based immunotherapy with venetoclax elicits synergistic cytotoxicity to B‐cell lines in vitro" (2020) (0)
[Flow cytometric analysis of cell surface antigens on leukemia cells by monoclonal antibodies and its application]. (1982) (0)
Anti-Myeloma Effects of a Novel Synthetic Retinoid Am80 (Tamibarotene) through Inhibition of Angiogenesis. (2005) (0)
[A case of pulmonary dirofilariasis that required differentiation from nontuberculous mycobacteriosis]. (2006) (0)
Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report. (2009) (0)
myeloid leukemia Biologic and clinical significance of the FLT3 transcript level in acute (2013) (0)
Contents Vol. 44, 2001 (2002) (0)
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]. (2015) (0)
Advances in Brief Wild-type but not Mutant p 53 Suppresses the Growth of Human Lung Cancer Cells Bearing Multiple Genetic Lesions 1 (2006) (0)
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement]. (1994) (0)
[A case of multiple myeloma with infiltration into skeletal muscle after injections of a granulocyte-colony stimulating-factor]. (2002) (0)
[Anemia in elderly patients with malignant tumors]. (1996) (0)
Bortezomib-Induced Apoptosis in Cutaneous T-Cell Lymphoma and Adult T-Cell Leukemia/Lymphoma Cells Partially Depends on up-Regulation of Noxa, Functional Repression of Mcl-1, and Down-Regulation of C-Flip and XIAP. (2008) (0)
Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy (2018) (0)
Ishida et al-2015-British Journal of Haematology (2016) (0)
Contents Vol. 50, 2004 (2004) (0)
Lymphocytic interstitial pneumonia and non-caseating epithelioid granuloma in mediastinal lymph nodes in a patient with primary Sjögren’s syndrome (1999) (0)
grants-in-aid for Research for Promotion of Cancer Control Programs (2015) (0)
Unexpected central-memory CD8+ T cell reduction hampers the antitumor efficacy of mogamulizumab (anti-CC chemokine receptor 4 mAb) treatment (2020) (0)
A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b. (2010) (0)
A Case of Gastrointestinal Stromal Tumor with Internal Tandem Duplication in the 3′-Terminal of the KIT Juxtamembrane Domain (2005) (0)
[Application of mouse monoclonal antibody to the diagnosis of cancer]. (1986) (0)
[Monoclonal antibody and purging]. (1989) (0)
Lymphoplasmacytic lymphoma and PAX-5 gene (1999) (0)
[Second syngeneic bone marrow transplantation in a case of erythroleukemia (author's transl)]. (1978) (0)
[Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy]. (2009) (0)
O2-7-3REACTIVATION OF HEPATITIS B VIRUS (HBV) IN HBV-RESOLVED PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA (2014) (0)
Mice In Vivonull γ IL-2 R , scid Human Immune Cells in NOD / Shi-Primary ATLL Cells Mediated by Autologous Antibody Exerts Potent ADCC against Defucosylated Anti-CCR 4 Monoclonal (2009) (0)
The role of thymidylate synthase as a biomarker for pemetrexed sensitivity in lung cancer (2007) (0)
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia (2021) (0)
Fluctuation of Serum HCV RNA Level during 12 Months in Individuals with Chronic Hepatitis C Virus Infection Who Had a Normal or Abnormal Serum ALT Level (1998) (0)
Familial clustering of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan (1997) (0)
Subject Index Vol. 49, 2006 (2006) (0)
Contents Vol. 49, 2006 (2006) (0)
T-cell lymphoma 504 THE CLINICAL SPECTRUM OF LARGE GRANULAR LYMPHOCYTIC LEUKAEMIA: A CASE SERIES (2008) (0)
Nouvel anticorps monoclonal (1984) (0)
Usefulness of Mycobacterium tuberculosis-specific enzyme-linked immunospot assay for the diagnosis of tuberculous pleurisy. (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ryuzou Ueda?

Ryuzou Ueda is affiliated with the following schools:

Ryuzou Ueda's Academic­Influence.com Rankings

Why Is Ryuzou Ueda Influential?

Ryuzou Ueda's Published Works

Published Works

What Schools Are Affiliated With Ryuzou Ueda?

Ryuzou Ueda's AcademicInfluence.com Rankings